This is week 4 of our Women in STEM careers series in collaboration with Shorla Oncology, where we introduce you to inspiring women making strides in science, technology, engineering, and mathematics. This week, meet Lisa, a dedicated professional at Shorla Oncology:
My name is Lisa Cleary, and I am a proud Tipperary woman, born and reared. However, I now have a combined Tipperary, Cork, and Waterford accent. I will explain a bit further later. I now live near Dunmore East in County Waterford and, as you can imagine, living here has given me a huge love for the sea. My hobbies are sea swimming, kayaking, sailing—anything to do with water, really. I have two children, Jane (12) and Ethan (almost 10), and their social lives keep me busy when I’m not in the water. I often say my second job is as a taxi driver.
Living in Waterford, especially so close to the coast, has deepened my connection with nature and the sea. Between balancing my professional life and my personal hobbies, I find that time spent outdoors helps me recharge and stay focused.
My Path to a Career in Science
My current job is as Director of Regulatory Affairs at Shorla Pharma, and I can explain how I got here. I always had an interest in Biology in school, and after my Leaving Certificate, I went to University College Cork, where I completed a degree in Microbiology. My initial course allowed me to study numerous science disciplines before branching out into my preferred area, which was Microbiology.
After completing my degree, I decided to pursue a higher diploma in Computer Science—a very different field, I know! However, years later, I was able to combine my two qualifications when I introduced a Laboratory Information System into the contract laboratory I worked in. This experience broadened my skillset and eventually led me to explore new opportunities.
Travel, Experience, and Finding My Passion in Regulatory Affairs
Before settling back into my career, I broadened my horizons with travel. I journeyed to Australia, passing through America, Fiji, and Southeast Asia—an experience of a lifetime. When I returned, I worked as a microbiologist in the pharmaceutical industry, which eventually led me to discover Regulatory Affairs. From there, I applied for a role, and the rest is history.
Life at Shorla Oncology
I’ve since worked in various pharmaceutical companies, across sterile biological products, solid oral dose, and generics. Now, at Shorla Oncology, my role involves ensuring that our oncology products are developed, registered, and approved to reach patients in need. I work closely with other teams to gather information for the authorities, demonstrating that our products are safe, effective, and of the highest quality.
The most fulfilling part of my job is collaborating with different teams and gaining knowledge from each phase of product development. Every day is an opportunity to learn something new.
Advice for Aspiring Women in Science
Working in STEM offers so many opportunities to move and grow within the industry. It’s an exciting journey to be on, with endless avenues to explore. My advice? Your future is always a work in progress, so it’s okay to take the scenic route to get where you want to go. Don’t be afraid to ask questions and stay curious—you never know where it might lead!
Are you inspired by Lisa’s story? Stay tuned for more women in STEM careers stories from the Shorla Oncology team over the coming weeks, or check out the previous stories here! Let us know if this is inspiring you to consider exploring your own path in science and technology! x
Shorla Oncology was established in 2018 by co-founders Sharon Cunningham (CEO) and Orlaith Ryan (CTO). Shorla Oncology is an Irish-US speciality pharmaceutical company that develops innovative solutions into effective oncology treatments to improve patients’ lives. The company has an advanced pipeline of innovative oncology drugs for orphan and pediatric cancers. Shorla is focused on indications where existing treatments are limited, in shortage or the drug applications are inadequate for the target population. The company’s growing portfolio brings accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care. Shorla currently markets two products, Nelarabine Injection for the treatment of T-cell Leukemia and JYLAMVO for the treatment of acute lymphoblastic leukemia and other indications. Recently Shorla Oncologys TEPYLUTE has been approved by the FDA to treat breast and ovarian cancer.
